ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 274 out of 1692

$445K Total Retail Price of All Prescriptions

Rank: 313 out of 1692

333 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 300 137 S3 1 6
LISINOPRIL 287 229 2 2
LEVOTHYROXINE SODIUM 287 220 2 4
OMEPRAZOLE 273 196 4 5
FUROSEMIDE 263 229 5 7
HYDROCHLOROTHIAZIDE 226 199 6 9
AMLODIPINE BESYLATE 211 183 7 3
PRAVASTATIN SODIUM 192 149 8 12
SIMVASTATIN 178 153 9 1
METFORMIN HCL 169 131 10 8
QUETIAPINE FUMARATE 149 128 11 62
POTASSIUM CHLORIDE 141 105 12 20
LAMOTRIGINE 130 47 13 191
ATENOLOL 125 101 14 15
CARVEDILOL 119 100 15 24
RISPERIDONE 106 85 16 77
SERTRALINE HCL 100 70 17 22
TRAZODONE HCL 98 77 18 33
GABAPENTIN 97 76 19 13
OXYCODONE-ACETAMINOPHEN 94 21 S2 20 70
LOSARTAN POTASSIUM 90 89 21 17
TRAMADOL HCL 90 74 21 16
METOPROLOL SUCCINATE 89 78 23 18
OXYCODONE HCL 89 0 S2 23 56
CITALOPRAM HBR 87 84 25 21
ATORVASTATIN CALCIUM 86 78 26 11
RANITIDINE HCL 85 59 27 28
PREDNISONE 85 53 27 35
SPIRONOLACTONE 83 82 29 74
WARFARIN SODIUM 82 82 30 14
TAMSULOSIN HCL 80 70 31 31
CRESTOR 78 62 32 26
CEPHALEXIN 77 65 33 89
AZITHROMYCIN 76 56 34 34
CYCLOBENZAPRINE HCL 76 16 R 34 54
METOPROLOL TARTRATE 72 53 36 10
ROPINIROLE HCL 72 49 36 101
DOXYCYCLINE HYCLATE 67 57 38 126
VENLAFAXINE HCL ER 66 40 39 84
DOXAZOSIN MESYLATE 62 52 40 83
FLUOXETINE HCL 61 29 41 52
GLIPIZIDE ER 61 59 41 87
DILTIAZEM 24HR CD 58 55 43 96
TIZANIDINE HCL 55 17 44 127
GLIPIZIDE 54 45 45 47
ALLOPURINOL 53 43 46 30
VENTOLIN HFA 52 13 47 151
POLYETHYLENE GLYCOL 3350 51 49 48 64
SEROQUEL 50 43 49 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.